Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
AbbVie
ABBV
|
+$3.06B |
| 2 |
Pfizer
PFE
|
+$1.93B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.67B |
| 4 |
Morgan Stanley
MS
|
+$1.59B |
| 5 |
Constellation Energy
CEG
|
+$1.25B |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$2.84B |
| 2 |
Exelon
EXC
|
+$2.5B |
| 3 |
Gilead Sciences
GILD
|
+$1.81B |
| 4 |
Union Pacific
UNP
|
+$1.68B |
| 5 |
Microsoft
MSFT
|
+$1.33B |
Sector Composition
| 1 | Technology | 23.02% |
| 2 | Financials | 14.78% |
| 3 | Healthcare | 14.09% |
| 4 | Communication Services | 11.78% |
| 5 | Industrials | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Sun Life Financial
SLF
$32.9B
| $300K | ﹤0.01% |
5,374
| – | – |
|
452
iShares Global 100 ETF
IOO
$7.23B
| $264K | ﹤0.01% |
3,425
-99,121
| -97% | -$7.64M |
|
453
Pembina Pipeline
PBA
$22.8B
| $218K | ﹤0.01% |
+5,805
| New | +$218K |
|
454
Adaptive Biotechnologies
ADPT
$2B
| – | – |
-2,093,732
| Closed | -$58.8M |
|
455
Booking.com
BKNG
$177B
| – | – |
-112,748
| Closed | -$271M |
|
456
BioMarin Pharmaceuticals
BMRN
$10.4B
| – | – |
-3,864
| Closed | -$344K |
|
457
Berkshire Hathaway Class A
BRK.A
$1.06T
| – | – |
-26
| Closed | -$11.7M |
|
|
458
Berkshire Hathaway Class B
BRK.B
$1.06T
| – | – |
-327,698
| Closed | -$98M |
|
459
SPDR MSCI ACWI ex-US ETF
CWI
$2.13B
| – | – |
-19,782
| Closed | -$581K |
|
460
EPAM Systems
EPAM
$8.61B
| – | – |
-320,097
| Closed | -$214M |
|
461
iShares Russell 1000 Value ETF
IWD
$63.6B
| – | – |
-4,155
| Closed | -$698K |
|
462
Coca-Cola
KO
$286B
| – | – |
-192,032
| Closed | -$11.4M |
|
|
KRON
463
DELISTED
Kronos Bio
KRON
| – | – |
-600,000
| Closed | -$8.15M |
|
464
Las Vegas Sands
LVS
$35.5B
| – | – |
-89,183
| Closed | -$3.36M |
|
465
Momentus
MNTS
$14.1M
| – | – |
-682
| Closed | -$2M |
|
|
NCNA
466
NuCana
NCNA
$8.76M
| – | – |
-595
| Closed | -$7.09M |
|
467
nCino
NCNO
$3.5B
| – | – |
-83,750
| Closed | -$4.6M |
|
468
NMI Holdings
NMIH
$2.99B
| – | – |
-1,412,927
| Closed | -$30.9M |
|
469
Novavax
NVAX
$1.39B
| – | – |
-235,000
| Closed | -$33.6M |
|
470
Organon & Co
OGN
$2.7B
| – | – |
-153,489
| Closed | -$4.67M |
|
471
Phreesia
PHR
$1.41B
| – | – |
-480,950
| Closed | -$20M |
|
472
PPG Industries
PPG
$24.5B
| – | – |
-2,576,867
| Closed | -$444M |
|
473
Privia Health
PRVA
$2.74B
| – | – |
-189,470
| Closed | -$4.9M |
|
474
PayPal
PYPL
$64B
| – | – |
-1,132,154
| Closed | -$214M |
|
475
Quince Therapeutics
QNCX
$87M
| – | – |
-1,461,827
| Closed | -$18.4M |
|